Trials / Completed
CompletedNCT05532475
Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Kasr El Aini Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the levels of TNF- α in vitreous samples of patients with retinal vein occlusion prior to administration of intravitreal anti-VEGF and compare them to levels in vitreous samples of normal subjects so as to investigate the association of vitreous tumor necrosis factor with the pathogenesis of retinal vein occlusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | measurement of vitreous level of tumor necrosis factor alpha | measurement of vitreous level of tumor necrosis factor alpha using ELISA technique |
Timeline
- Start date
- 2022-03-12
- Primary completion
- 2022-10-20
- Completion
- 2022-10-30
- First posted
- 2022-09-08
- Last updated
- 2024-11-27
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05532475. Inclusion in this directory is not an endorsement.